California Pharmaceutical Research Institute, Inc.

Anaheim, California 92804

0 studies enrolling now · 8 studies all time

What they study most

Depressive Disorder, Major, Schizophrenia

Studies at this site

• A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy — Completed
• A Study of Paliperidone Palmitate 6-Month Formulation — Completed
• Study of Rapastinel as Monotherapy in Patients With MDD — Stopped early
• Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) — Stopped early
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) — Completed
• Pediatric Schizophrenia Efficacy and Safety Study — Completed